Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nanoscale Disruptive Technology Kills Pathogens on Touch

By HospiMedica International staff writers
Posted on 10 Mar 2015
Innovative surface technology kills pathogens in an environmentally conscious way, without generating resistant microbes which are difficult to treat.

NanoSeptic self-cleaning surfaces are composed of antimicrobial components that provide a non-leaching, self-cleaning surface that constantly kills bacteria, viruses, and fungi utilizing molecularly bonded nanotechnology and a light-powered catalytic oxidation process. More...
The surface is also hydrophilic, so that water, oils, dirt, and other contaminants are actively shed. The surfaces are available in standard sizes for door push pads, door handle wraps, door push bar pads, equipment and cart handle wraps, and even disposable mouse pads. The adhesive wrappings are peeled off and replaced periodically.

Maintenance includes routine cleaning with soap and water or stronger cleansers, and does not affect the efficacy of the surface. While the surfaces are self-cleaning at a microscopic level, they can still become soiled or stained if exposed to coffee, wine, or suchlike, but will continue to function as long as no abrasive products that can physically wear or damage them are used. The NanoSeptic self-cleaning surfaces are manufactured by NanoTouch Materials (Forest, VA, USA), and have an effective life in the healthcare setting of 90 days, as long as he surface is not worn.

“When it comes to healthcare, we’re thrilled that our approach aligns with the Hippocratic Oath which states that doctors should ‘first, do no harm,’” said Dennis Hackemeyer, co-founder of NanoTouch Materials. “Since the NanoSeptic surface doesn’t use chemicals, poisons, or heavy metals, we aren’t adding any toxins to the environment, and it doesn’t contribute to antimicrobial resistance.”

Related Links:

NanoTouch Materials



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.